VRDN SCHEDULE 13G/A: SEC filing

T. Rowe Price Associates

Filed with the SEC on · accession 0000080255-26-000699

VRDN filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. T. Rowe Price Associates filed an amended Schedule 13G reporting beneficial ownership of 5,123,592 shares, or 4.5%, of Viridian Therapeutics common stock as of September 30, 2026. The stock moved -3.5% by the first close after the filing.

Summary of the filing

T. Rowe Price Associates filed an amended Schedule 13G reporting beneficial ownership of 5,123,592 shares, or 4.5%, of Viridian Therapeutics common stock as of September 30, 2026. The filing is a passive investment disclosure with no intent to influence control of the company.

Key details

Shares beneficially owned$5.1M
Percent of class beneficially owned$5
Reporting beneficial owner (filer)T. Rowe Price Associates, Inc.
Issuer of the securitiesViridian Therapeutics, Inc.
Vice president, t. rowe price associates, inc.Ellen York

How VRDN stock reacted

Close before

$30.87

Nov 13, 2026

First close after

-3.47%

$29.80

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for VRDN, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for VRDN?

Click here

Frequently asked questions

What did VRDN file with the SEC on Nov 16, 2026?

VRDN filed a SCHEDULE 13G/A (SEC filing). T. Rowe Price Associates filed an amended Schedule 13G reporting beneficial ownership of 5,123,592 shares, or 4.5%, of Viridian Therapeutics common stock as of September 30, 2026. The filing is a passive investment disclosure with no intent to influence control of the company.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did VRDN stock react to this filing?

VRDN closed at $30.87 before the filing and $29.80 on Nov 16, 2026 (-3.47%).

Other VRDN SEC filings

Get alerts when VRDN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days